EFTR
Vanguard Group’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-25,070
| Closed | -$7.27K | – | 4454 |
|
|
2024
Q2 | $7.27K | Sell |
25,070
-67,395
| -73% | -$19.6K | ﹤0.01% | 4400 |
|
|
2024
Q1 | $1.33M | Sell |
92,465
-481,948
| -84% | -$6.94M | ﹤0.01% | 3720 |
|
|
2023
Q4 | $268K | Buy |
574,413
+170,387
| +42% | +$79.6K | ﹤0.01% | 4178 |
|
|
2023
Q3 | $242K | Sell |
404,026
-1,893
| -0.5% | -$1.14K | ﹤0.01% | 4218 |
|
|
2023
Q2 | $337K | Hold |
405,919
| – | – | ﹤0.01% | 4216 |
|
|
2023
Q1 | $143K | Sell |
405,919
-23,124
| -5% | -$8.16K | ﹤0.01% | 4368 |
|
|
2022
Q4 | $183K | Hold |
429,043
| – | – | ﹤0.01% | 4322 |
|
|
2022
Q3 | $245K | Sell |
429,043
-87,755
| -17% | -$50.1K | ﹤0.01% | 4386 |
|
|
2022
Q2 | $734K | Hold |
516,798
| – | – | ﹤0.01% | 4181 |
|
|
2022
Q1 | $2.07M | Buy |
516,798
+634
| +0.1% | +$2.54K | ﹤0.01% | 3943 |
|
|
2021
Q4 | $4.27M | Buy |
+516,164
| New | +$4.27M | ﹤0.01% | 3695 |
|